ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 255 filers reported holding ICU MED INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $252,970,751 | -33.3% | 2,125,626 | -0.2% | 0.01% | -33.3% |
| Q2 2023 | $379,515,655 | +7.8% | 2,129,837 | -0.2% | 0.01% | 0.0% |
| Q1 2023 | $352,030,909 | +6.2% | 2,134,038 | +1.4% | 0.01% | 0.0% |
| Q4 2022 | $331,365,006 | +6.7% | 2,104,172 | +2.0% | 0.01% | 0.0% |
| Q3 2022 | $310,568,000 | -9.0% | 2,062,205 | -0.7% | 0.01% | -10.0% |
| Q2 2022 | $341,435,000 | -27.7% | 2,076,981 | -2.1% | 0.01% | -9.1% |
| Q1 2022 | $472,466,000 | +2.1% | 2,122,104 | +8.8% | 0.01% | 0.0% |
| Q4 2021 | $462,873,000 | +4.8% | 1,950,253 | +3.0% | 0.01% | 0.0% |
| Q3 2021 | $441,750,000 | +15.5% | 1,892,836 | +1.8% | 0.01% | +10.0% |
| Q2 2021 | $382,605,000 | +0.9% | 1,859,110 | +0.7% | 0.01% | 0.0% |
| Q1 2021 | $379,286,000 | -2.1% | 1,846,215 | +2.3% | 0.01% | -9.1% |
| Q4 2020 | $387,232,000 | +19.8% | 1,805,362 | +2.1% | 0.01% | 0.0% |
| Q3 2020 | $323,192,000 | -4.6% | 1,768,395 | -3.8% | 0.01% | -8.3% |
| Q2 2020 | $338,636,000 | -9.2% | 1,837,318 | -0.6% | 0.01% | -25.0% |
| Q1 2020 | $373,107,000 | +8.9% | 1,849,170 | +1.0% | 0.02% | +33.3% |
| Q4 2019 | $342,609,000 | +20.5% | 1,830,957 | +2.7% | 0.01% | +9.1% |
| Q3 2019 | $284,407,000 | -35.7% | 1,782,000 | +1.5% | 0.01% | -35.3% |
| Q2 2019 | $442,327,000 | +3.5% | 1,755,894 | -1.7% | 0.02% | 0.0% |
| Q1 2019 | $427,385,000 | +5.0% | 1,785,757 | +0.7% | 0.02% | -5.6% |
| Q4 2018 | $407,124,000 | -2.9% | 1,772,957 | +19.5% | 0.02% | +12.5% |
| Q3 2018 | $419,459,000 | +7.8% | 1,483,501 | +12.0% | 0.02% | 0.0% |
| Q2 2018 | $388,999,000 | +17.8% | 1,324,703 | +1.3% | 0.02% | +14.3% |
| Q1 2018 | $330,164,000 | +9.7% | 1,308,100 | -6.1% | 0.01% | +7.7% |
| Q4 2017 | $300,960,000 | +18.3% | 1,393,332 | +1.8% | 0.01% | +8.3% |
| Q3 2017 | $254,484,000 | +13.1% | 1,369,301 | +5.0% | 0.01% | +9.1% |
| Q2 2017 | $224,989,000 | +31.4% | 1,304,282 | +16.3% | 0.01% | +22.2% |
| Q1 2017 | $171,199,000 | -8.3% | 1,121,149 | -11.5% | 0.01% | -10.0% |
| Q4 2016 | $186,652,000 | +16.2% | 1,266,725 | -0.3% | 0.01% | +11.1% |
| Q3 2016 | $160,620,000 | +12.4% | 1,270,929 | +0.3% | 0.01% | 0.0% |
| Q2 2016 | $142,890,000 | +5.5% | 1,267,318 | -2.6% | 0.01% | 0.0% |
| Q1 2016 | $135,417,000 | -8.0% | 1,300,837 | -0.3% | 0.01% | -10.0% |
| Q4 2015 | $147,212,000 | -72.4% | 1,305,293 | -88.0% | 0.01% | -50.0% |
| Q3 2015 | $534,074,000 | +399.5% | 10,912,403 | +876.4% | 0.02% | +185.7% |
| Q2 2015 | $106,916,000 | +17.2% | 1,117,671 | +14.1% | 0.01% | +16.7% |
| Q1 2015 | $91,210,000 | +18.4% | 979,274 | +4.1% | 0.01% | 0.0% |
| Q4 2014 | $77,018,000 | +30.4% | 940,394 | +2.2% | 0.01% | +20.0% |
| Q3 2014 | $59,055,000 | +6.4% | 920,148 | +0.8% | 0.01% | +25.0% |
| Q2 2014 | $55,518,000 | +2.9% | 912,978 | +1.3% | 0.00% | -20.0% |
| Q1 2014 | $53,967,000 | -0.5% | 901,259 | +5.8% | 0.01% | 0.0% |
| Q4 2013 | $54,263,000 | -2.2% | 851,730 | +4.2% | 0.01% | 0.0% |
| Q3 2013 | $55,505,000 | -13.9% | 817,089 | -8.7% | 0.01% | -28.6% |
| Q2 2013 | $64,503,000 | – | 895,122 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |